MedPath

Surveillance for esophageal cancer using NBI endoscopy

Not Applicable
Recruiting
Conditions
Superficial esophageal squamous cell carcinoma
Registration Number
JPRN-UMIN000013700
Lead Sponsor
Osaka City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) esophageal and pharyngeal stricture (2) previous surgical resection or chemotherapy, radiotherapy, or chemoradiotherapy for esophageal SCC (3) patients with active malignant cancer or presence of serious complications (liver, kidney, heart, blood, or metabolic disorders) (4) other reasons which made the subject ineligible to participate in this study, at the discretion of the chief investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
5 years control rate by endoscopic surveillance and endoscopic resection
Secondary Outcome Measures
NameTimeMethod
incident rate of metachronous esophageal cancer, 5 years survival rate, accuracy of magnified NBI endoscopy, clinical and pathological characteristics of metachronous esophageal cancer
© Copyright 2025. All Rights Reserved by MedPath